William Fearon, MD

Back to Profile

Publication Details

  • Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.

    Farouque HM, Tremmel JA, Raissi Shabari F, Aggarwal M, Fearon WF, Ng MK, Rezaee M, Yeung AC, Lee DP. J Am Coll Cardiol. 2005; 45 (3): 363-8

    We sought to determine the incidence, clinical features, and risk factors for retroperitoneal hematoma (RPH) after percutaneous coronary intervention (PCI).

    PubMedID: 15680713

Stanford Medicine Resources:

Footer Links: